维普期刊资源整合服务平台（V6.5）

22篇 您的检索式：作者名="Jaglowski"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	A phase1/1bstudy of combined rituximab,bendamustine,and ibrutinib in patients with previously untreated and relapsed/refractory non-Hodgkin's lymphoma显示文摘	Maddocks K Christian B Jaglowski S	2015	Blood2015，125，：	1
2	Combination chemotherapy with gemcitabine and biotherapy with opioid growth factor(OGF)enhances the growth inhibition of pancre- atic adenocareinomal显示文摘	Zagon I S Jaglowski J R Verderame M F	2005	Cancer Chemother Pharmacol2005，56，5：	1
3	Opioid growlh factor enhances tumor growth inhibition and increases the survival of paclitaxel-treated mice with squamous cell carcinoma of the head and neck显示文摘	Jaglowski JR Zagon IS Stack BC	2005	Cancer Chemother Pharmacol2005，56，1：	1
4	Lymphoma in adolescents and young adults 显示文摘	Jaglowski SM Linden E Termuhlen AM	2009	Semin Oncol2009，36，5：	1
5	Ibrutinib显示文摘	ANDRITSOS L A JAGLOWSKI S M	2013	Drugs Future2013，38，6：	1
6	Combination chemotherapy with gemcitabine and biotherapy with opioid growth factor (OGF) enhances the growth inhibition of pancreatic adenocarcinoma 显示文摘	Zagon IS Jaglowski JR Verderame MF	2005	Cancer Ghemother Pharmacol2005，56，5：	1
7	Enhanced growth inhibition of squamous cell carcinoma of the head and neck by combination therapy of paclitaxel and opioid growth factor显示文摘	McLaughlin PJ Jaglowski JR Verderame MF	2005	Int J Oncol2005，26，3：	1
8	En- hanced growth inhibition of squamous cell carcinoma of the head and neck by combination therapy of paclitaxel and opioid growth factorl显示文摘	McLaughlin P J Jaglowski J R Verderame M F	2005	Int J Oncol2005，26，3：	1
9	Lymphoma in adolescents and young adults显示文摘	Jaglowski SM Linden E Termuhlen AM	2009	Semin Oncol2009，36，5：	1
10	The clinical application of monoclonal antibodies in chronic lymphocytic leukemia显示文摘	Jaglowski S M Alinari L Lapalombella R	2010	Blood2010，116，19：	1
11	The clinical application of monoclonal antibodies in chronic lympho-cytie leukemia显示文摘	JAGLOWSKI SM ALINAR1 L LAPALOMBELLA R	2010	Blood2010，116，19：	1
12	Effects of ozonation on the permeate flux of nanocrystalline ceramic membranes显示文摘	Bhavana S. Karnik Simon H.R. Davies Kuan C. Chen David R. Jaglowski Melissa J. Baumann S.J. Masten	2004	Water Research2004，，4：	1
13	Lymphoma in adolescents and young adults显示文摘	Jaglowski SM Linden E Termuhlen AM	2009	Semin Oncol2009，36，5：	1
14	Enhanced growth inhibition of squamous cell carcinoma of the head and neck by combination therapy of fusaric acid and paclitaxel or carboplatin 显示文摘	Jaglowski J R Stack Jr B C	2006	Cancer Letters2006，243，1：	1
15	The clinicalapplica- tion of monoclonal antibodies in chronic lymphocytic leukemia显示文摘	Jaglowski SM Alinari L Lapalombella R	2010	Blood2010，116，19：	1
16	Combination chemotherapy with gemcitabine and biotherapy with opioid growth factor (OGF) enhances the growth inhibition of pancreatic adenocarcinoma显示文摘	Ian S. Zagon Jeffrey R. Jaglowski Michael F. Verderame Jill P. Smith Alphonse E. Leure-duPree Patricia J. McLaughlin	2005	Cancer Chemotherapy and Pharmacology2005，，5：	1
17	The clinical application of monoclonal antibodies in chronic lymphocytic leukemia显示文摘	Jaglowski S M Alinari L Lapalombella R	2010	Blood2010，116，19：	1
18	A phase Ⅰb/Ⅱ study evaluating activity and tolerability of BTK inhibitor PCI-32765 and ofatumumab in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) and related diseases显示文摘	Jaglowski SM Jones J Flynn J		0，，15：	1
19	Aphase Ib/ H study evaluating activity and tolerability of BTK inhibitor PCI-32765 and ofatumumab in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma(CLL/SLL)and related diseases显示文摘	Jaglowski SM Jones JA Flynn JM	2012	ASCO Meeting Abstracts2012，30，15：	1
20	A phase Ib/II study evaluating activity and tolerability of BTK inhibitor PCI-32765 and ofatumumab in patients with chronic lym-phocytic leukemia/small lymphocytic lymphoma(CLL/SLL)and related diseases显示文摘	Jaglowski SM Jones JA Flynn JM		0，，：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示